NGVT icon

Ingevity

38.15 USD
-1.44
3.64%
Updated Apr 1, 3:01 PM EDT
1 day
-3.64%
5 days
-12.16%
1 month
-15.67%
3 months
-3.52%
6 months
0.69%
Year to date
-3.52%
1 year
-19.50%
5 years
8.63%
10 years
62.34%
0
Funds holding %
of 7,398 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

20% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 76

6% more capital invested

Capital invested by funds: $1.41B [Q3] → $1.49B (+$83.1M) [Q4]

1.3% more ownership

Funds ownership: 99.4% [Q3] → 100.7% (+1.3%) [Q4]

3% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 33

2% less funds holding

Funds holding: 260 [Q3] → 255 (-5) [Q4]

32% less call options, than puts

Call options by funds: $77K | Put options by funds: $114K

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$65
70%
upside
Avg. target
$65
70%
upside
High target
$65
70%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
BMO Capital
John McNulty
34% 1-year accuracy
16 / 47 met price target
70%upside
$65
Outperform
Upgraded
26 Feb 2025

Financial journalist opinion

Based on 10 articles about NGVT published over the past 30 days

Positive
Zacks Investment Research
1 week ago
Ingevity's Shares Up 10% in 6 Months: What's Driving the Stock?
NGVT gains on the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.
Ingevity's Shares Up 10% in 6 Months: What's Driving the Stock?
Neutral
Business Wire
1 week ago
Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity today announced that it has filed its definitive proxy statement with the U.S. SEC in connection with its 2025 Annual Meeting.
Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders
Negative
Zacks Investment Research
1 week ago
Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?
Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?
Positive
Zacks Investment Research
2 weeks ago
Why Ingevity (NGVT) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Ingevity (NGVT) is a Top Momentum Stock for the Long-Term
Positive
Zacks Investment Research
3 weeks ago
Why Ingevity (NGVT) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Ingevity (NGVT) is a Top Growth Stock for the Long-Term
Neutral
Business Wire
3 weeks ago
Ingevity announces appointment of David H. Li as president and CEO
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced that its board of directors has appointed David H. Li as the company's president and CEO, effective as of April 7, 2025.
Ingevity announces appointment of David H. Li as president and CEO
Positive
Zacks Investment Research
3 weeks ago
Here's What Makes Ingevity Stock a Solid Choice Right Now
NGVT benefits from the repositioning of its Performance Chemicals segment to rationalize its manufacturing footprint and strategic acquisitions.
Here's What Makes Ingevity Stock a Solid Choice Right Now
Neutral
Zacks Investment Research
3 weeks ago
Zacks Industry Outlook Axalta Coating, Ingevity and Flexible Solutions International
Axalta Coating, Ingevity and Flexible Solutions International have been highlighted in this Industry Outlook article.
Zacks Industry Outlook Axalta Coating, Ingevity and Flexible Solutions International
Positive
Zacks Investment Research
4 weeks ago
5 Stocks With Upgraded Broker Ratings Worth Betting on Now
Brokers have more insights into stocks and the macroeconomic backdrop. One must follow broker rating upgrades to pick stocks like NGVT, STRL, NVDA, PYPL & AAL.
5 Stocks With Upgraded Broker Ratings Worth Betting on Now
Neutral
Zacks Investment Research
4 weeks ago
3 Chemical Specialty Stocks to Watch Amid Industry Challenges
Soft end-market demand dampens the prospects of the Zacks Chemicals Specialty industry. AXTA, NGVT and FSI are set to gain from strategic actions to navigate the ongoing challenges.
3 Chemical Specialty Stocks to Watch Amid Industry Challenges
Charts implemented using Lightweight Charts™